Article
Enhanced Effector Activity of Mediator Kinase Module Deficient CAR-T Cells
2022-09-04
Abstract excerpt
Adoptive T cell immune therapies mediate impressive clinical benefit in a fraction of patients, but anti-tumor effects are often limited by inadequate T cell potency. To identify genes limiting T cell effector function, we conducted genome-wide CRISPR knock-out screens in human primary CAR-T cells. The top hits were MED12 and CCNC , components of the cyclin-dependent kinase (CDK) module of the Mediator complex,...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d5eeb574-df1f-5a96-a3a9-0bb79c95e3a6
- DOI
- 10.1101/2022.09.02.506235
